The Association Between Body Mass Index and Remission Rates in Patients With Treatment-Resistant Depression Who Received Intravenous Ketamine

J Clin Psychiatry. 2019 Nov 12;80(6):19l12852. doi: 10.4088/JCP.19l12852.

Authors

Affiliations

¹ Department of Psychiatry and Psychology, Mayo Clinic Depression Center, Mayo Clinic College of Medicine, Rochester, Minnesota, USA.
² Department of Psychiatry and Psychology, Mayo Clinic College of Medicine, Jacksonville, Florida, USA.
³ Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA.
⁴ vandevoort.jennifer@mayo.edu.

PMID: 31721482
DOI: 10.4088/JCP.19l12852

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Adult
Bipolar Disorder / diagnosis
Bipolar Disorder / drug therapy*
Bipolar Disorder / psychology
Body Mass Index*
Clinical Trials as Topic
Depressive Disorder, Treatment-Resistant / diagnosis
Depressive Disorder, Treatment-Resistant / drug therapy*
Depressive Disorder, Treatment-Resistant / psychology
Drug Administration Schedule
Female
Humans
Infusions, Intravenous
Ketamine / administration & dosage*
Male
Middle Aged
Treatment Outcome

Substances

Ketamine